These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 1288493

  • 1. Lower susceptibility of low density lipoprotein to in vitro oxidation in diabetic patients.
    Taus M, Ferretti G, Curatola G, Dousset N, Solèra ML, Valdiguie P.
    Biochem Int; 1992 Dec; 28(5):835-42. PubMed ID: 1288493
    [Abstract] [Full Text] [Related]

  • 2. Physico-chemical properties of copper-oxidized high density lipoprotein: a fluorescence study.
    Ferretti G, Taus M, Dousset N, Solera ML, Valdiguié P, Curatola G.
    Biochem Mol Biol Int; 1993 Jul; 30(4):713-9. PubMed ID: 8401329
    [Abstract] [Full Text] [Related]

  • 3. Study of fluidity of low density lipoproteins from liver cirrhotic patients.
    Taus M, Dousset N, Moreau J, Ferretti G, Galeazzi T, Soléra ML, Curatola G, Valdiguié P.
    Nutr Metab Cardiovasc Dis; 1999 Dec; 9(6):289-93. PubMed ID: 10765521
    [Abstract] [Full Text] [Related]

  • 4. Effect of glycaemic control and age on low-density lipoprotein susceptibility to oxidation in diabetes mellitus type 1.
    Liguori A, Abete P, Hayden JM, Cacciatore F, Rengo F, Ambrosio G, Bonaduce D, Condorelli M, Reaven PD, Napoli C.
    Eur Heart J; 2001 Nov; 22(22):2075-84. PubMed ID: 11686665
    [Abstract] [Full Text] [Related]

  • 5. HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients.
    Sanguinetti SM, Brites FD, Fasulo V, Verona J, Elbert A, Wikinski RL, Schreier LE.
    Diabetes Nutr Metab; 2001 Feb; 14(1):27-36. PubMed ID: 11345163
    [Abstract] [Full Text] [Related]

  • 6. Impaired oxidant/antioxidant status and LDL-fatty acid composition are associated with increased susceptibility to peroxidation of LDL in diabetic patients.
    Merzouk S, Hichami A, Sari A, Madani S, Merzouk H, Yahia Berrouiguet A, Lenoir-Rousseaux JJ, Chabane-Sari N, Khan NA.
    Gen Physiol Biophys; 2004 Dec; 23(4):387-99. PubMed ID: 15815074
    [Abstract] [Full Text] [Related]

  • 7. Autoantibodies to oxidized low density lipoprotein: the relationship to low density lipoprotein fatty acid composition in diabetes.
    Griffin ME, McInerney D, Fraser A, Johnson AH, Collins PB, Owens D, Tomkin GH.
    Diabet Med; 1997 Sep; 14(9):741-7. PubMed ID: 9300223
    [Abstract] [Full Text] [Related]

  • 8. The susceptibility of low-density lipoprotein to in vitro oxidation is increased in hypercholesterolemic patients.
    Cominacini L, Pastorino AM, Garbin U, Campagnola M, de Santis A, Davoli A, Faccini G, Bertozzo L, Pasini F, Pasini AF.
    Nutrition; 1994 Sep; 10(6):527-31. PubMed ID: 7703599
    [Abstract] [Full Text] [Related]

  • 9. Susceptibility to copper-enhanced autoxidation of VLDL+LDL fractions from diabetic patients.
    Gugliucci A, Menini T, Stahl AJ.
    Biochem Mol Biol Int; 1994 Jan; 32(1):139-47. PubMed ID: 8012279
    [Abstract] [Full Text] [Related]

  • 10. Paraoxonase-1 (PON-1) genotype and activity and in vivo oxidized plasma low-density lipoprotein in Type II diabetes.
    Sampson MJ, Braschi S, Willis G, Astley SB.
    Clin Sci (Lond); 2005 Aug; 109(2):189-97. PubMed ID: 15853770
    [Abstract] [Full Text] [Related]

  • 11. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
    González AI, Schreier L, Elbert A, Berg G, Beresan H, López G, Wikinski R.
    Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
    [Abstract] [Full Text] [Related]

  • 12. Effect of desialylation on low density lipoproteins: comparative study before and after oxidative stress.
    Dousset N, Dousset JC, Taus M, Ferretti G, Curatola G, Soléra ML, Valdiguié P.
    Biochem Mol Biol Int; 1994 Mar; 32(3):555-63. PubMed ID: 8032323
    [Abstract] [Full Text] [Related]

  • 13. C-reactive protein inhibits in vitro oxidation of low-density lipoprotein.
    Rufail ML, Ramage SC, van Antwerpen R.
    FEBS Lett; 2006 Oct 02; 580(22):5155-60. PubMed ID: 16962105
    [Abstract] [Full Text] [Related]

  • 14. Reduced antioxidant potential & sensitivity to oxidation in plasma low density lipoprotein fraction in type 2 diabetes mellitus patients.
    Ergüder IB, Karagenç N, Karaca L.
    Indian J Med Res; 2006 Aug 02; 124(2):207-10. PubMed ID: 17015936
    [Abstract] [Full Text] [Related]

  • 15. Enhanced susceptibility of low-density lipoprotein to in vitro oxidation in type 1 and type 2 diabetic patients.
    Beaudeux JL, Guillausseau PJ, Peynet J, Flourie F, Assayag M, Tielmans D, Warnet A, Rousselet F.
    Clin Chim Acta; 1995 Aug 14; 239(2):131-41. PubMed ID: 8542651
    [Abstract] [Full Text] [Related]

  • 16. Copper-induced low density lipoprotein oxidation is not a risk discriminator for intermittent claudication.
    Ziedén B, Mölgaard J, Olsson AG.
    Vasa; 1996 Aug 14; 25(2):121-6. PubMed ID: 8659213
    [Abstract] [Full Text] [Related]

  • 17. The relationship of chemical modification of membrane proteins and plasma lipoproteins to reduced membrane fluidity of erythrocytes from diabetic subjects.
    Watala C, Winocour PD.
    Eur J Clin Chem Clin Biochem; 1992 Sep 14; 30(9):513-9. PubMed ID: 1457612
    [Abstract] [Full Text] [Related]

  • 18. Modified fluidity and lipid composition in lipoproteins and platelet membranes from diabetic patients.
    Rabini RA, Ferretti G, Galassi R, Taus M, Curatola G, Tangorra A, Fumelli P, Mazzanti L.
    Clin Biochem; 1994 Oct 14; 27(5):381-5. PubMed ID: 7867216
    [Abstract] [Full Text] [Related]

  • 19. Organization of phosphatidylcholine and sphingomyelin in the surface monolayer of low density lipoprotein and lipoprotein(a) as determined by time-resolved fluorometry.
    Sommer A, Prenner E, Gorges R, Stütz H, Grillhofer H, Kostner GM, Paltauf F, Hermetter A.
    J Biol Chem; 1992 Dec 05; 267(34):24217-22. PubMed ID: 1447171
    [Abstract] [Full Text] [Related]

  • 20. Absence of increased susceptibility of LDL to oxidation in type 1 diabetics.
    O'Brien SF, Mori TA, Puddey IB, Stanton KG.
    Diabetes Res Clin Pract; 1995 Dec 05; 30(3):195-203. PubMed ID: 8861459
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.